2218 ⎘
Animals characterised by purpose; Animal model, e.g. for test or diseases Animal model for proliferative diseases
Means and methods for treating cancer
#302IN VIVO ADCC MODEL
#303Systems and methods for preclinical models of metastases
#304Non-human animals having a humanized signal-regulatory protein gene
#305Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#306Compounds for inducing proliferation and differentiation of cells, and methods of use thereof
#307Activation of innate immunity by miRNA for cancer and infection treatment
#308Animal models of cancer
#309Non-human animals having a humanized programmed cell death 1 gene
#310Methods of treating, preventing and diagnosing leukemia and other blood diseases and disorders
#311Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#312Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors
#313Cancer treatment and immune system regulation through FAT10 pathway inhibition
#314MODELING ANTI-LEUKEMIC THERAPY BY PATIENT DERIVED AML XENOGRAFTS WITH DISTINCT PHENOTYPES/GENOTYPES
#315ANIMAL MODEL WITH HUMAN IMMUNE SYSTEM
#316Method of establishing isogenic multi-xenograft model and the use thereof
#317MMTV-SV40-Spy1A and Spy1A-pTRE transgenic mouse models
#318MELANOCORTIN RECEPTOR MUTANT MOUSE AND USES THEREOF
#319Mitochondrial-nuclear exchanged cells, tissues, organs and animals
#320Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors
#321Genetically modified non-human animals and methods of use thereof
#322Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#323Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#324MMTV-SV40-Spy1A and Spy1A-pTRE Transgenic Mouse Models
#325Fumarylacetoacetate hydrolase (Fah)-deficient pigs and uses thereof
#326Anti-tumor properties of Dickkopf 3b
#327Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
#328Methods And Compositions Comprising A Drosophila Model Of Amyotrophic Lateral Sclerosis
#329Cell line of renal sarcomatoid carcinoma in persons of Han nationality and preparation method thereof
#330METHODS OF INCREASING THE NUMBER OF TARGET CELLS RECOVERED FROM A FLUID SAMPLE
#331Method for preparing patient-specific glioblastoma animal model, and uses thereof
#332Non-human animals having a humanized signal-regulatory protein gene
#333Non-human animals having a humanized signal-regulatory protein gene
#334METHOD FOR ENHANCING TUMOR GROWTH
#335Humanized IL-7 rodents
#336Production of fertile XY female animals from XY ES cells
#337Transgenic immunodeficient mouse expressing human SIRP-alpha
#338HUMANIZED MOUSE
#339Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells
#340Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
#341PIK3CA H1047R Knock-In Non-Human Animal Breast Cancer Model
#342Production and use of red blood cells
#343Nonhuman mammal whose mtDNA is from a nonhuman mammal resistant to a selected disease or disorder and whose nDNA is from a nonhuman donor mammal more susceptible to the selected disease or disorder
#344Soluble protein CD5 or CD6 for the treatment of cancer or tumor or for use as an adjuvant
#345Steatohepatitis-liver cancer model animal
#346WDR13 as a novel biomarker useful for treating diabetes and cancer
#347MMTV-SV40-Spy1A and Spy1A-pTRE transgenic mouse models
#348Tumor model system useful to study multistage cancer
#349Genetically modified mice and engraftment
#350Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#351Mesothelin vaccines and model systems
#352Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#353Humanized IL-7 rodents
#354Method to enhance delivery of glutathione and ATP levels in cells
#355LMCD1 CANCER MARKERS AND METHODS FOR THEIR USE
#356Use of herpes vectors for tumor therapy
#357Compositions and methods to control angiogenesis with cupredoxins
#358Screening method for anticancer drugs
#359MicroRNA as a cancer progression predictor and its use for treating cancer
#360Methods for inhibiting hematopoiesis with a hedgehog antagonist
#361Use of riluzole for treating or preventing the adverse effects of antineoplastic agents
#362Identification and Enrichment of Cell Subpopulations
#363Identification and Enrichment of Cell Subpopulations
#364Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#365Recurrent gene fusions in prostate cancer
#366Genetically modified mice and engraftment
#367PROTEIN FRAGMENT COMPLEMENTATION ASSAYS FOR THE DETECTION OF BIOLOGICAL OR DRUG INTERACTIONS
#368Genetically modified mice and engraftment
#369Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein
#370Recurrent gene fusions in prostate cancer
#371Recurrent gene fusions in prostate cancer
#372Stem Cell Fusion Model of Carcinogenesis
#373GENETICALLY DETERMINED MOUSE MODEL OF RESISTANCE TO TRANSPLANTABLE CANCERS
#374Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers
#375Fish cancer model
#376GLYCINE N-METHYLTRANSFERASE (GNMT) ANIMAL MODEL AND USE THEREOF
#377METHODS AND COMPOSITIONS RELATING TO ZPA POLYPEPTIDES
#378MicroRNA as a cancer progression predictor and its use for treating cancer
#379Non-Human Mammal Model Of Human Hematopoietic Cancer
#380Catenae: Serosal Cancer Stem Cells
#381Transgenic mouse conditionally expressing MMP12 for studying myelopoiesis, immunity and tumorigenesis
#382METHODS OF MONITORING ENDOPLASMIC RETICULUM (ER) STRESS RESPONSE
#383UBIQUITIN INTERACTING MOTIF PEPTIDES AS CANCER THERAPEUTICS
#384Compositions and methods to control angiogenesis with cupredoxins
#385Genetically modified rat models for severe combined immunodeficiency (SCID)
#386Mouse model for diagnosis of T cell acute lymphoblastic leukemia and for screening of therapeutic agents, and methods of use therefor
#387Methods Of Producing Humanized Non-Human Mammals
#388Treatment of astrocytes-tumor cells inhibitors of endothelin receptors
#389Compositions and methods for treating and diagnosing pancreatic cancer
#390Isolation and growth of stem cells from hemangiomas
#391STEATOHEPATITIS-LIVER CANCER MODEL ANIMAL
#392CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
#393ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES
#394TRANSGENIC LSD1 ANIMAL MODEL FOR CANCER
#395Methods for producing microRNAs
#396Chromosome 3p21.3 genes are tumor suppressors
#397Mesothelin vaccines and model systems
#398TARGETING OF SALL4 FOR THE TREATMENT AND DIAGNOSIS OF PROLIFERATIVE DISORDERS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME (MDS)
#399COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#400Production of fertile XY animals from XY ES cells
#401Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
#402Protein fragment complementation assays for the detection of biological or drug interactions
#403MODULATING ANGIOGENESIS
#404Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
#405THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF
#406Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#407Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer
#408Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin
#409ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#410Evaluation/screening method for diseases associated with D-amino acid utilizing DAO1-/-mouse
#411Genetically modified mice and engraftment
#412Transgenic animal for screening of compounds that modulate cell proliferation, and its use in the pharmaceutical field
#413Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-37
#414RODENT CANCER MODEL FOR HUMAN FGFR4 ARG388 POLYMORPHISM
#415CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES
#416Tumor model system useful to study multistage cancer
#417METHODS AND COMPOSITIONS FOR TREATING FUS1 RELATED DISORDERS
#418USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA
#419Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#420DKAT CELL LINE, A MODEL FOR HUMAN TRIPLE-NEGATIVE BREAST CANCER
#421BIOMARKERS FOR MONITORING OR PREDICTING THE TREATMENT OF CANCER
#422Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
#423Animal Model of Synovial Sarcoma
#424Chd5 is a novel tumor suppressor gene
#425METHODS OF USING FLT3-LIGAND IN THE TREATMENT OF CANCER
#426HEAT SHOCK PROTEIN DEFICIENCIES AS MODEL SYSTEMS FOR BRAIN PATHOLOGY AND CANCER
#427Monoclonal antibody capable of binding to anexelekto, and use thereof
#428Mosaic knockout mouse tumor models and methods or use
#429COOPERATING ONCOGENES IN CANCER
#430Recurrent gene fusions in prostate cancer
#431COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY
#432Transgenic Animal Model of Cancer and Methods of Use
#433Compositions and Methods for Cancer Treatment
#434GENOMIC EDITING OF GENES INVOLVED IN TUMOR SUPPRESSION IN ANIMALS
#435RECOMBINANT NEWCASTLE DISEASE VIRUS
#436Thymidylate Kinase Mutants and Uses Thereof
#437Production of human antibodies using NOD/SCID/γmice
#438Treatment of squamous cell carcinoma with HSP27 antisense oligonucleotides and radiotherapy
#439METHOD FOR INHIBITING ANGIOGENESIS OR FOR TREATMENT OF CANCER
#440TREM-2 gene and protein as inhibitors of expression of GA733-2, and transgenic animals comprising the same and uses thereof
#441TUMOR SUPPRESSOR GENE SCREENING USING RNA INTERFERENCE LIBRARIES AND METHOD OF TREATMENT
#442NEURAL TUMOR STEM CELLS AND METHODS OF USE THEREOF
#443WNT PATHWAY MUTATIONS IN CANCER STEM CELLS
#444Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
#445Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis
#446Glycine N-methyltransferase (GNMT) Animal model and use thereof
#447ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORS
#448Transgenic animals comprising gene fusions
#449METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#450Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same
#451Antisense modulation of kinesin-like 1 expression
#452GRP78 AND TUMOR ANGIOGENESIS
#453Non-human animal model for lung carcinoma
#454PROGNOSTIC MARKER FOR BREAST CANCER AND COMPOSITION FOR INDUCING OBESITY COMPRISING HCCR-1
#455Regulation of expression of PI3Kβ protein in tumors
#456Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
#457Isolation of novel AAV'S and uses thereof
#458TARGETED GENE DISRUPTIONS IN THE IQGAP2 GENE
#459Tumor-initiating cells and methods of use
#460METHODS AND COMPOSITIONS RELATING TO ZPA POLYPEPTIDES
#461METHOD OF PRODUCING A MULTICHIMERIC MOUSE AND APPLICATIONS TO STUDY THE IMMUNOPATHOGENESIS OF HUMAN TISSUE-SPECIFIC PATHOLOGIES
#462METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
#463TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE
#464PIG MODEL FOR BREAST CANCER, MITOCHONDRIA RELATED PROTEIN FOLDING DISORDERS AND/OR EPIDERMOLYSIS BULLOSA SIMPLEX
#465Methods for Assessing the Delivery of Exogenous Agents
#466Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
#467ZIRCONIUM-RADIOLABELED, CYSTEINE ENGINEERED ANTIBODY CONJUGATES
#468Probe for visualizing cell-cycle
#469Models of malignant brain cancer, and therapeutic siRNAs against oncogenic signaling pathways, and methods and kits for uses therefor
#470Immunocompetent xenograft model
#471Oncolytic Adenoviruses and Uses Thereof
#472PROTEIN KINASE C IOTA
#473Cancer Compositions, Animal Models, and Methods of Use Thereof
#474Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
#475ENHANCED RESOLUTION OF TUMOR METASTASIS USING A SKIN FLAP MODEL
#476Transgenic non-human animal models of apoptosis-mediated conditions
#477ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINS
#478CD20 negatively converted B-cell malignant lymphoma cell line and utilization thereof
#479Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions
#480Prostate Epithelial Androgen Receptor Suppresses Prostate Growth and Tumor Invasion
#481PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis
#482Compositions and methods to control angiogenesis with cupredoxins
#483Cysteine engineered antibodies and conjugates
#484MITOCHONDRIAL-NUCLEAR EXCHANGED CELLS, TISSUES, ORGANS AND ANIMALS
#485Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
#486Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
#487ANIMAL MODELS CARRYING TUMORS EXPRESSING HUMAN PROSTATE CANCER-SPECIFIC ANTIGEN AND METHOD FOR ANALYZING PREVENTION AND TREATMENT EFFICACY OF DENDRITIC CELLS-DERIVED IMMUNOTHERAPEUTICS
#488MODULATING ANGIOGENESIS
#489Anti-IL-6 antibodies, compositions, methods and uses
#490INDUCTION OF APOPTOSIS IN TOLL-LIKE RECEPTOR EXPRESSING TUMOR CELLS
#491ABI1 conditional knockout mouse
#492Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#493RNAi Therapeutics for Treatment of Eye Neovascularization Diseases
#494Compositions and methods for inducing tumor resistance
#495USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER
#496Chemical inhibitors of inhibitors of differentiation
#497Transgenic mouse model of B cell malignancy
#498VACCINE DELIVERY SYSTEM
#499Cell-based RNA interference and related methods and compositions
#500Non-human animal sarcoma model
#501Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
#502Recurrent gene fusions in prostate cancer
#503Mutant Herpes Simplex Viruses Comprising Nucleic Acid Encoding A Nitroreductase
#504Model for studying the role of genes in chemoresistance
#505Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
#506Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells
#507Cysteine engineered antibodies and conjugates
#508Use of fructose-based compounds for the diagnosis of cancer
#509DIRECTED COMPLEMENTATION WITH REMOVABLE GENE OF INTEREST
#510RORS as modifiers of the p21 pathway and methods of use
#511Methods and compositions for modulating and detecting wisp activity
#512Glycine N-methyltransferase (GNMT) Animal model and use thereof
#513Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#514Inducible SIRNA expression cassette and method of use
#515PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS
#516Protein and peptide fragments from mouse telomerase reverse transcriptase
#517Mesothelin Vaccines and Model Systems and Control of Tumors
#518BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
#519Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
#520Cell lines and animal models of HER2 expressing tumors
#521Methods for producing microRNAs
#522THYMIDYLATE KINASE MUTANTS AND USES THEREOF
#523ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINS
#524Pharmaceutical composition for treating or preventing ovarian cancer
#525Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery
#526ZEBRAFISH MODEL OF MLL LEUKEMOGENESIS
#527FcγRIIB specific antibodies and methods of use thereof
#528Use of herpes vectors for tumor therapy
#529Estrogen receptor intramolecular folding systems, estrogen receptor intramolecular folding sensors, methods of use thereof, methods of detecting ER ligands, and methods of detecting ER agonists and antagonists
#530Method to enhance delivery of glutathione and ATP levels in cells
#531AMPK Deficient Animals, Screening Methods, And Related Therapeutics And Diagnostics
#532Glycine N-methyltransferase (GNMT) animal model and use thereof
#533Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
#534Chromosome 3p21.3 genes are tumor suppressors
#535Orthotopic, controllable, and genetically tractable non-human animal model for cancer
#536Chicken growth differentiation factor-8
#537TREATMENT OF CANCER WITH ANTI-MUSCARINIC RECEPTOR AGENTS
#538Therapeutic uses of factors which inhibit or neutralize MIF activity
#539Transgenic non-human animal model of lung tumorigenesis
#540Anti-IL-6 antibodies, compositions, methods and uses
#541DEFECTIVE SINDBIS VIRAL VECTORS
#542ISOLATION AND GROWTH OF STEM CELLS FROM HEMANGIOMAS
#543Tumor mouse models using lentiviral vectors
#544Methods for developing animal models
#545Fish cancer model
#546Method of Constructing Animal Having Cancer Cells Transplanted Thereinto
#547Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses
#548ALK protein tyrosine kinase, cells and methods embodying and using same
#549Compositions and methods for treating and diagnosing pancreatic cancer
#550Imaging reporters of transgene expression
#551Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
#552ANIMAL MODEL FOR PROSTATIC STROMAL HYPERPLASIA
#553Animal models of pancreatic adenocarcinoma and uses therefor
#554Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
#555Transgenic animal model
#556COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#557Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
#558COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#559COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#560Compositions and methods for the therapy and diagnosis of prostate cancer
#561COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#562Animal model for cancer, methods of producing the same and associated methods of use
#563NOVEL C. ELEGANS P21-ACTIVATED KINASE (PAK) GENE AND ASSOCIATED LOSS-OF-FUNCTION PHENOTYPES THAT FACILITATE SCREENING FOR SMALL MOLECULE MODULATORS OF PAK ACTIVITY IN THE NEMATODE, CAENORHABDITIS ELEGANS
#564Recombinant Newcastle Disease Virus
#565ANTI-ANGIOGENIC PROTEIN, COMPOSITION AND USE THEREOF
#566GRP94-BASED COMPOSITIONS AND METHODS OF USE THEREOF
#567Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
#568Frizzled proteins and detection and treatment of cancer
#569NON-MAMMALIAN TRANSGENIC ANIMAL MODEL FOR CELLULAR PROLIFERATIVE DISEASES
#570Role of FGF-20 in cancer diagnosis and treatment
#571Combined gene therapy for the treatment of macroscopic gliomas
#572Growth Differentiation Factor-8 Nucleic Acid and Polypeptide from Aquatic Species, and Transgenic Aquatic Species
#573DEFECTIVE SINDBIS VIRAL VECTORS
#574In vivo amplification of neural progenitor cells
#575Protein fragment complementation assays in whole animals applications to drug efficacy, adme, cancer biology, immunology, infectious disease and gene therapy
#576Method for Inducing Mammary Epithelial Cell Differentiation
#577Method for treatment and prevention of ultraviolet light induced skin pathologies
#578Casein kinase 2 antisense therapy
#579Therapeutic methods for inhibiting tumor growth with DII4 antagonists
#580Compositions and methods to control angiogenesis with cupredoxins
#581MOUSE MODELS TO STUDY CACHEXIA
#582Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#583Defective Sindbis viral vector comprising an anti-tumor gene
#584Braf Expression in Zebrafish and Uses Thereof
#585Non-Human Animal Models for B-cell Non-Hodgkin's Lymphoma and Uses Thereof
#586Regulation of oncogenesis by Akt-specific isoforms
#587Animal Model of Prostate Cancer and Use Thereof
#588Administration of gamma globulins to treat metastatic melanoma
#589Method for inhibiting NOX1 gene expression
#590Method of Suppressing Cancer
#591Methods and compositions for identifying biomarkers
#592Antisense modulation of kinesin-like 1 expression
#593Chimeric cancer models
#594Anti-IL-6 antibodies, compositions, methods and uses
#595Method for testing a compound for a therapeutic effect and a diagnostic method
#596Low-density lipoprotein receptor 6 (LRP6) as a mammary stem cell marker and related methods
#597ANIMAL MODELS OF TUMOR METASTASIS AND TOXICITY
#598Protein kinase C iota
#599Mammary stem cell marker
#600Use of Caspase-8 Inhibitors for Modulating Hematopoiesis